(NasdaqGM:CRML), NEW YORK, Dec. 09, 2025 (GLOBE NEWSWIRE) — Critical Metals Corp. (Nasdaq: CRML) (“Critical Metals Corp.” or the “Company”), a leading critical minerals mining company, today announced that it has executed the Term-Sheet for creating a 50%-50% joint venture (JV) between CRML and Fabrica de Prelucrare a Concentratelor de Uraniu S.R.L. (FPCU) of Romania, […]

(NASDAQ:SHFS), DENVER, Dec. 09, 2025 (GLOBE NEWSWIRE) — SHF Holdings, Inc., d/b/a Safe Harbor Financial (“Safe Harbor” or the “Company”) (NASDAQ: SHFS), a provider of banking, lending, and financial services to the legal cannabis industry, announced that Canopy HR–one of the largest payroll-service providers in the cannabis sector–selected Safe Harbor to support nearly all of

(NASDAQ:SNTI), RMAT designation indicates that SENTI-202 has the potential to address unmet medical needs for patients with Relapsed/Refractory (R/R) Acute Myeloid Leukemia (AML) based on preliminary clinical evidence, and offers benefits of FDA working closely with Senti Bio to provide guidance and advice on generating the data needed to support approval of the product in

(NASDAQ:SNTI), ASH 2025 oral presentation on SENTI-202 in 20 Relapsed/Refractory Acute Myeloid Leukemia (R/R AML) patients (18 response evaluable) shows high efficacy: 50% ORR and 42% CR/CRh (100% of CRs and 83% of all responses were MRD negative) at RP2D, 7.6 months median duration of composite Complete Remission across all patients, and a favorable safety

(NasdaqGM:OLLI), Store Openings, Sales, and Earnings Ahead of Expectations Net Sales Increased 18.6% and Earnings Per Share Increased 29.3% Raising Fiscal 2025 Sales and Earnings Outlook HARRISBURG, Pa., Dec. 09, 2025 (GLOBE NEWSWIRE) — Ollie's Bargain Outlet Holdings, Inc. (NASDAQ: OLLI) (the “Company”) today announced financial results for the third quarter ended November 1, 2025.

(TSX-V:SYH),(OTC US:SYHBF),(Other OTC:SYHBF),(Boerse Frankfurt – Freiverkehr:SC1P), Vancouver, BC, Dec. 09, 2025 (GLOBE NEWSWIRE) — Skyharbour Resources Ltd. (TSX-V: SYH) (OTCQX: SYHBF) (Frankfurt: SC1P) (“Skyharbour” or the “Company”) is pleased to announce that its joint-venture partner, Orano Canada Inc. (“Orano”), is planning a substantial 2026 exploration and drilling program at the 49,635 hectare Preston Uranium Project

(NASDAQ:OSRH),(NasdaqGM:SBC),(TSX-V:DDD),(Other OTC:NBYCF),(PinkSheets:RGBP),(NASDAQ:KLXE),(Other OTC:XBOTF),(NYSE MKT:GRO),(NASDAQ:JAGX),(Other OTC:PUMXF),(NASDAQ:XXII),(NASDAQ:OMEX),(NASDAQ:CLNN),(NASDAQ:FFAI), MIAMI, Dec. 09, 2025 (GLOBE NEWSWIRE) — EmergingGrowth.com a leading independent small cap media portal announces the schedule of the 88th Emerging Growth Conference on December 10 & 11, 2025. The Emerging Growth Conference identifies companies in a wide range of growth sectors, with strong management teams, innovative products &

EXTON, Pa., Dec. 09, 2025 (GLOBE NEWSWIRE) — Lungpacer Medical, a leader in innovative respiratory care neurostimulation technologies, today announced that physicians at one of the nation's largest healthcare providers and top hospitals has performed the first commercial procedures using the company's FDA-approved AeroPace(R) System, marking a major milestone in the clinical adoption of diaphragm

(TSX-V:PUR),(OTC US:PAUIF),(Other OTC:PAUIF), TORONTO, Dec. 09, 2025 (GLOBE NEWSWIRE) — Premier American Uranium Inc. (“PUR” or “Premier American Uranium” or the “Company”) (TSXV: PUR, OTCQB: PAUIF) is pleased to announce the filing of a technical report (the “Technical Report“) containing its Preliminary Economic Assessment (“PEA“) and updated Mineral Resource Estimate (“MRE“) for the Cebolleta Uranium

SUNRISE, Fla., Dec. 09, 2025 (GLOBE NEWSWIRE) — Transpire Bio, an integrated, clinical-stage biopharmaceutical company focused on developing inhaled therapeutics for pulmonary and systemic diseases, today announced that the U.S. FDA has completed a Pre-Approval Inspection (PAI) at its manufacturing facility in Weston, Florida, with a Voluntary Action Indicated (VAI) classification. The company has now